Page
%P
-
Article
Open AccessExploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
Mantle cell lymphoma (MCL) is a lethal hematological malignancy with a median survival of 4 years. Its lethality is mainly attributed to a limited understanding of clinical tumor progression and resistance to ...
-
Article
Open AccessDnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia